Status:
NOT_YET_RECRUITING
Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients
Lead Sponsor:
Assiut University
Conditions:
Pressor Response
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Dexmedetomidine nebulization in sever preeclamptic patients
Detailed Description
Dexmedetomidine nebulization for attenuation of pressor response to laryngoscopy and endotracheal intubation in sever preeclamptic patients undergoing caesarean section under general anaesthesia. A pr...
Eligibility Criteria
Inclusion
- Patients with severe pre-eclampsia scheduled for cesarean section under general anesthesia
- ASA II, III
Exclusion
- sever obesity (BMI ≥ 40)
- Cardiac patients
- History of diabetes mellitus
- Renal dysfunction (elevated serum creatinine \> 2mg\\dl)
- hepatic dysfunction (elevated hepatic enzyme three times above normal)
- History to hypersensitivity to the tested drug.
- Emergency surgery
- Known fetal anomalies
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07164326
Start Date
October 15 2025
End Date
December 15 2026
Last Update
September 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.